Hathal Haddad: Thank you to the Prostate Brachytherapy – UK and Ireland and Mount Vernon Cancer Centre for An Excellent Conference
Hathal Haddad/ LinkedIn

Hathal Haddad: Thank you to the Prostate Brachytherapy – UK and Ireland and Mount Vernon Cancer Centre for An Excellent Conference

Hathal Haddad, Head of Interventional Radiotherapy Unit at the Department of Radiation Oncology at University Hospital Tübingen, shared Prostate Brachytherapy – UK and Ireland’s post on LinkedIn, adding:

“Thank you to the Prostate Brachytherapy – UK & Ireland and Mount Vernon Cancer Centre for the kind invitation and outstanding organization of this excellent conference.

It was a pleasure to engage in inspiring discussions on prostate cancer treatment and exchange knowledge with leading experts, physicists, radiographers, and nurses from across the UK and beyond.

Together, we will continue to promote and expand awareness of Interventional – Radiotherapy (Brachytherapy), highlighting both its advantages and limitations to support informed treatment decisions and deliver the best possible care for our patients.

Looking forward to future collaborations and advancing prostate cancer care together.”

Quoting Prostate Brachytherapy – UK & Ireland’s post:

“What a two days!

The UK & Ireland Prostate Brachytherapy Conference 2026 has wrapped up, and we couldn’t be prouder of what we achieved together at Vicarage Road, Watford.

Over 11–12 June, clinicians, physicists, radiographers and nurses from across the UK and beyond came together to share expertise, debate innovation, and shape the future of prostate brachytherapy. The energy in the room was outstanding.

A heartfelt thank you to our invited speakers:

  • Peter Orio (Dana Faber Cancer Institute, USA)
  • Ann Henry (Leeds teaching hospital)
  • Dr. med. Dr. Hathal Haddad (University of Tubingen, Germany)
  • Albert Edwards (Kent Oncology Centre)

…whose insights and expertise elevated the scientific programme to another level.

Thank you to every presenter and abstract contributor — the breadth and quality of work on display was a true reflection of the strength of brachytherapy across our community.

A very special thank you to our industry partners, without whom none of this would be possible:
BXTA | Elekta | Boston Scientific | Teleflex | Novartis | Eckert & Ziegler SE | Seedos Ltd | Siemens Healthineers | East and North Hertfordshire NHS Trust

And above all — an enormous thank you to the incredible organising team at Mount Vernon Cancer Centre for hosting this year’s conference with such dedication, warmth and professionalism. You set the bar high.

See you at the next one – handed over to the amazing team at the Royal Surrey County Hospital team!”

Hathal Haddad

Other articles featuring Hathal Haddad and Prostate Brachytherapy – UK & Ireland on OncoDaily.